XML 17 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 6 Months Ended 153 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Cash flows from operating activities:      
Income (loss) for the period $ 4,525,009 $ (1,920,192) $ (20,561,670)
Adjustments to reconcile income (loss) for the period to net cash used in operating activities:      
Depreciation 16,610 14,724 208,327
Increase in liability for employee rights upon retirement    108 196,506
Stock-based compensation 19,854 12,472 1,635,898
Stock-based interest compensation to convertible notes holders       1,214,943
Issuance costs allocated to warrants with down-round protection    390,928 390,928
Change in the fair value of warrants issued with round down protection (6,293,705) (68,643) (78,355)
Linkage difference on principal of loans from stockholders (1,315) 11,567 199,965
Interest on convertible notes       78,192
Gain on sale of property and equipment       (912)
Gain from trading marketable securities       (12,920)
Changes in assets and liabilities:      
Decrease (increase) in other current assets (24,756) 6,526 (99,408)
Increase in accounts payable 118,346 49,577 163,079
Increase (decrease) in other current liabilities 83,862 (19,194) 317,505
Net cash used in operating activities (1,556,095) (1,522,127) (16,347,922)
Cash flows from investment activities:      
Increase in funds in respect of employee rights upon retirement    (42,313) (149,221)
Purchase of property and equipment (47,919) (33,963) (332,291)
Proceeds from sale of property and equipment       4,791
Investment in marketable securities       (388,732)
Proceeds from sale of marketable securities       406,995
Short-term loan granted to related party, net of repayments       (14,252)
Net cash used in investment activities (47,919) (76,276) (472,710)
Cash flows from financing activities      
Credit from banking institutions (repayment)    (38,140) (8,671)
Proceeds from issuance of convertible notes       1,144,000
Repayment of convertible notes       (527,396)
Proceeds from issuance of Common Stock, net of issuance expenses       11,323,559
Dividend to Preferred Stock holders (185,263) (15,750) (473,511)
Proceeds allocated to convertible Preferred Stock, net of issuance expenses    3,960,958 3,960,958
Proceeds allocated to warrants with "down-round" protection, net of issuance expenses    1,421,983 1,421,983
Proceeds from stockholders loans       347,742
Net cash provided by (used in) financing activities (185,263) 5,329,051 17,188,664
Effect of exchange rate changes on cash and cash equivalents (6,898) 47,215 221,704
Increase (decrease) in cash and cash equivalents (1,796,175) 3,777,863 589,736
Cash and cash equivalents at beginning of the period 2,385,911 543,411   
Cash and cash equivalents at end of the period $ 589,736 $ 4,321,274 $ 589,736